# Prostate Reirradiation Toxicity Outcomes Feasibility Study

> **NCT05614700** · NA · NOT_YET_RECRUITING · sponsor: **University of Leeds** · enrollment: 60 (estimated)

## Conditions studied

- Prostate Cancer
- Radiotherapy Side Effect

## Interventions

- **RADIATION:** Brachytherapy
- **RADIATION:** Sterotactic Body Radiotherapy

## Key facts

- **NCT ID:** NCT05614700
- **Lead sponsor:** University of Leeds
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-11-15
- **Primary completion:** 2024-11-15
- **Final completion:** 2026-11-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05614700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05614700, "Prostate Reirradiation Toxicity Outcomes Feasibility Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05614700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*